From online gaming, invisibility and uranium, I take you fellas to the world of
######l suppositories, courtesy of another Canadian small fry called
BioSyent. It's one I own personally and it's a large holding of our funds. Terrific management with a high caliber CEO who makes himself accessible to us - something we look for in management as we tend to specialize in smaller companies that have room for growth. Currently not covered on the street and very under the radar, this is a company with a history of under promising and over delivering. Obviously, the stock has had a great run in the last year so if you are buying now you're buying at the top. Might be one to put on your watch list and add on dips.
Still laughing at the language filter here. What are we, 7? Come on....
Anyhow, this thinly traded Canadian pusher of VULVA (can we say vulva here?) suppositories and FeraMax (treats iron deficiency) is going to announce Q2 earnings next week, most likely on Thursday. Now, I don't know much about anything in life, but I know to trust my boss when I see him excited upon hanging up the phone with a CEO, which is what he was after talking to the CEO of Biosyent. His words: "This guy cannot WAIT to release his numbers".
Volume is miniscule, float is tiny, CEO is the largest shareholder. Guy loves to under promise and over deliver. I have a hunch that he is going to blow away the expectations. I've added a little bit personally and it continues to be a decent sized name in our portfolios.
As always, buyer beware, remember my lengthy list of stupidity here and do your own homework.